Ignite Creation Date:
2024-05-06 @ 7:43 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02583906
Status:
TERMINATED
Last Update Posted:
2023-01-27
First Post:
2014-04-28
Brief Title:
Sleep Disordered Breathing in Precapillary Pulmonary Hypertension Effect of CPAP Treatment
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Universitaire Ziekenhuizen KU Leuven
Study Overview
Official Title:
Sleep Disordered Breathing in Precapillary Pulmonary Hypertension Effect of CPAP Treatment
Status:
TERMINATED
Status Verified Date:
2020-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not enough participants
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluation of the effect of CPAP continuous positive airway pressure treatment in PAH pulmonary arterial hypertension and CTEPH chronic thromboembolic pulmonary hypertension patients suffering from sleep disordered breathing
Detailed Description:
The primary endpoint of the study is to evaluate the effect of CPAP therapy on pulmonary vascular resistance in PAH and CTEPH patients suffering from sleep disordered breathing
The secondary endpoints are the effect of CPAP on right atrium and right ventricle diameter and ejection fraction measured by echocardiography 6 minutes walk distance NYHA class QOL endothelial function sympathetic activity and prognosis
The secondary endpoints are the effect of CPAP on right atrium and right ventricle diameter and ejection fraction measured by echocardiography 6 minutes walk distance NYHA class QOL endothelial function sympathetic activity and prognosis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None